Xiaodan Qian
Changzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Immune checkpoint inhibitor-associated diabetic ketoacidosis induced by cadonilimab: a case report and literature review.
Journal: Frontiers in endocrinology
Published: February 28, 2026
Characteristics of indications, clinical trial evidence, clinical benefits and the costs of price-negotiated multi-indication drugs for solid tumours in China.
Journal: Journal of global health
Published: May 08, 2025
Cost-effectiveness of PD-1 inhibitors combined with chemotherapy for first-line treatment of oesophageal squamous cell carcinoma in China: a comprehensive analysis.
Journal: Annals of medicine
Published: March 25, 2025
Impact of the national health insurance coverage policy on mecapegfilgrastim utilization for chemoradiotherapy-induced neutropenia in cancer patients in China: a retrospective real-world analysis.
Journal: Frontiers in pharmacology
Published: December 16, 2024
An Empirical Comparison of Discrete Choice Experiment and Best-Worst Scaling to Estimate Patient Preferences in Infertility Treatment in China.
Journal: Patient preference and adherence
Published: October 30, 2024
Cost-effectiveness of tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma: a comparative analysis in China, the United States and Europe.
Journal: International journal of clinical pharmacy
Published: September 07, 2024
Cost-effectiveness of camrelizumab plus chemotherapy versus chemotherapy alone as first-line therapy in advanced or metastatic esophageal squamous cell carcinoma.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: May 16, 2023
Molecular mechanism of Ginkgo biloba in treating type 2 diabetes mellitus combined with non-alcoholic fatty liver disease based on network pharmacology, molecular docking, and experimental evaluations.
Journal: Journal of food biochemistry
Published: June 08, 2022
Evaluation of CD4/CD8 ratio in children with immune thrombocytopenic purpura (ITP) after treatment with intravenous immunoglobulin (IVIG).
Journal: Cellular and molecular biology (Noisy-le-Grand, France)
Published: May 24, 2022
Trends of Antibiotic Use and Expenditure After an Intensified Antimicrobial Stewardship Policy at a 2,200-Bed Teaching Hospital in China.
Journal: Frontiers in public health
Published: June 23, 2021
Cost-Effectiveness Analysis of Anlotinib as Third- or Further-Line Treatment for Relapsed Small Cell Lung Cancer (SCLC) in China.
Journal: Advances in therapy
Published: May 24, 2021
Last Updated: 09/26/2026